期刊文献+

奥施康定治疗中重度癌痛的临床观察 被引量:13

下载PDF
导出
摘要 目的观察奥施康定治疗中重度癌痛的疗效及不良反应、生活质量。方法对30例癌性中重度疼痛患者进行治疗,其中男19例,女11例。疼痛类型:头痛、胸痛、骨痛、腹痛等。奥施康定剂型为5mg,由患者主诉疼痛明显时给药,且均为首次服用奥施康定。初始剂量10mg.12h-1,服用24h如疼痛评分下降不到3分,则第二天加量至20mg.12h-1,以此类推,最多至50mg.12h-1。在用药过程中根据疼痛缓解程度调整剂量,所有患者均连续用药3周。结果 30例慢性癌性中重度疼痛患者使用的奥施康定最小剂量10mg.12h-1,最大剂量50mg.12h-1。治疗效果:完全缓解11例,部分缓解16例,轻度缓解3例。其中中度疼痛患者的显效率为100.0%,重度疼痛患者的显效率为88%,全部患者总的显效率为90.0%。不良反应有便秘、恶心呕吐、腹胀、厌食、嗜睡、头晕等。患者的生活质量评分用药后与用药前相比有所提高。结论奥施康定治疗慢性癌性中重度疼痛疗效确切,有效率高,不良反应轻,服用安全。
出处 《海峡药学》 2010年第6期169-170,共2页 Strait Pharmaceutical Journal
  • 相关文献

参考文献3

二级参考文献10

  • 1Sunshine A,Olson NZ,Colon A,et al.Analgesic efficacy of controlled-release oxycodone in postoperative pain[J].J Clin Pharmacol,1996,36(7):595~603
  • 2Mandema JW,Kaiko RF,Oshlack B,ct al.Characterization and validation of a pharmacokinetic model for controlled-release oxycodone[J].BrJ Clin Pharmacol,1996,42(6):747~756
  • 3Hagen NA,Babul N.Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlledrelease hydromorphone in the treatment of cancer pain[J].Cancer,1997,79(7):1428~1437
  • 4Heiskanen T,Kalso E.Controlled-release oxycodone and morphine in cancer related pain[J].Pain,1997,73(1):37~45
  • 5Bruera E,Belzile M,Pituskin E,et al.Randomized,double-blind,cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-relea se morphine in patients with cancer pain[J].J Clin Oncol,1998,16 (10):3222~3229
  • 6Kaplan R,Parris WC,Citron ML,et al.Comparison of controlled-release and immediate-release oxycodone tablets in patients with cancer pain[J].J Clin Oncol,1998,16(10):3230~3237
  • 7Salzman RT,Roberts MS,Wild J,et al.Can a controlled-release oral dose form of oxycodone be used as readily as an immediaterelease form for the purpose of titrating to stable pain control[J]?J Pain Symp Manage,1999,18(4):271~279
  • 8Czarnecki ML,Jandrisevits MD,Theiler SC,et al.Controlledrelease oxycodone for the management of pediatric postoperative pain[J].J Pain Symp Manage,2004,27(4):379~386
  • 9Hanks GW,Conno F,Cherny N,et al.Morphine and alternative opioids in cancer pain:the EAPC recommendations[J].Br J Cancer,2001,84(5):587~593
  • 10Benitez-Rosario MA,Feria M,Salinas-Martin A,et al.Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain[J].Cancer,2004,101(12):2866~2873

共引文献53

同被引文献62

  • 1刘华,王蔚,郑垂志,邢雪花.癌症三阶梯止痛563例分析[J].中国肿瘤临床,2004,31(23):1346-1348. 被引量:79
  • 2杨俊,陶京,王春友,熊炯忻,魏海燕.术中腹腔神经丛阻滞术对不能切除的胰腺癌疼痛减轻及生活质量的影响[J].临床外科杂志,2006,14(2):114-116. 被引量:10
  • 3朱正勇,曾飞聆.盐酸羟考酮新剂型——奥施康定~[J].海峡药学,2007,19(7):82-83. 被引量:21
  • 4吴华.癌痛病因病机及证治述略[J].实用中医内科杂志,2007,21(5):3-5. 被引量:10
  • 5中华人民共和国卫生部.涉及人的生物医学研究伦理审查办法(试行)[S].(2007-03-26)[2010-04-05].http://www.moh.gov.cn/qjjys/s3581/200804/b9f1bfee4ab344ec892e68097296e2a8.shtml.
  • 6Hawes RH. The evolution of endoscopic uhrasound; improved imaging, higher accuracy for fine needle aspiration and the reality of endoscopic ultrasoundguided interventions[J]. Curt Opin Gastroenterol, 2010,26: 436--444.
  • 7Sun Y, Shi YK. Clinical cancer medicine manual[M]. Beijing: People' s Medical Publishing House, 2007 : 527.
  • 8Ballantyne JC. Chronic pain following treatment for cancer: the role of opioids[J]. The Oncologist,2003,8 ( 6 ) : 567-575.
  • 9Parkin DM, Bray F, Feray J, et al. Global cancer statistics[J].CA Cancer J Clin, 2005,55 : 74-108.
  • 10Baron TH, Kozarek RA. Preoperative biliary stents in pancreatic cancer-proceed with caution[J].N Engl J Med, 2010,362: 170-172.

引证文献13

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部